Consumer Products
Personal Care
Biopharmaceutical
Veru
$2.289876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-1.72%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Veru and other stocks, options, ETFs, and crypto commission-free!
About VERU
Veru Inc. Common Stock, also called Veru, is a urology and oncology biopharmaceutical company, which engages in the development, manufacture and marketing of consumer health care products. Read More It operates through the Commercial; and Research and Development segments. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. The company was founded by William R. Gargiulo Jr. and O.B. Parrish in 1971 and is headquartered in Miami, FL.
Employees
171
Headquarters
Miami, Florida
Founded
1971
Market Cap
146.92M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
315.84K
High Today
$2.37
Low Today
$2.24
Open Price
$2.34
Volume
115.92K
52 Week High
$2.49
52 Week Low
$1.18
Collections
Consumer Products
Personal Care
Biopharmaceutical
Advertising and Marketing
Healthcare
Research And Development
Retail
Pharmaceutical
Price Paid on Robinhood
46% Higher
Right Now
52 Week Low
$1.18
Average Price Paid
$1.56
52 Week High
$2.37
VERU Earnings
-$0.15
-$0.11
-$0.07
-$0.03
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Aug 8, Pre-Market